OMB control number
Collection of Prescription Drug Data from MA-PD, PDP and Fallout Plans/Sponsors for Medicare Part D Payments (CMS-10174) - IRA
OMB 0938-0982 ยท HHS/CMS.
CMS requires contracted Part D providers to submit prescription drug event (PDE) records as required by the Medicare Prescription Drug Improvement, and Modernization Act of 2003. The PDE data is then used in the Payment Reconciliation System to perform the annual Part D payment reconciliation, any PDE data within the Coverage Gap Phase of the Part D benefit is used for invoicing in the CGDP, and the data are part of the report provided to the Secretary of the Treasury for Section 9008. Section 11102 of the Inflation Reduction Act of 2022 establishes a Part D inflation rebate by manufacturers of certain single source drugs and biologicals with prices increasing at a rate faster than the rate of inflation. CMS will use data reported under sections 1860D-15(c)(1)(C) and (d)(2), in part, to rank drugs by total expenditures under Part D in order to select drugs for negotiation and to identify units to calculate inflation rebates. We also intend to use the PDE data submissions from Part D sponsors to fulfill our statutory obligations under the Social Security Act. This includes the use of PDE data to fulfill obligations or operationalize any future legislative changes to the Social Security Act that impact the Part D program. CMS is notifying users that it will also use data reported under sections 1860D-15(c)(1)(C) and (d)(2) to implement the Medicare Drug Negotiation Program and to calculate inflation rebates as required by the Inflation Reduction Act of 2022, as well as to fulfill our statutory obligations under the Social Security Act. This includes the use of PDE data to fulfill obligations or operationalize any future legislative changes to the Social Security Act that impact the Part D program.
The latest form for Collection of Prescription Drug Data from MA-PD, PDP and Fallout Plans/Sponsors for Medicare Part D Payments (CMS-10174) - IRA expires 2027-04-30 and can be found here.
Document Name |
|---|
Supporting Statement A |
Supplementary Document |
|
Approved without change |
Revision of a currently approved collection | 2024-03-05 | |
|
Approved without change |
Revision of a currently approved collection | 2023-07-18 | |
|
Comment filed on proposed rule and continue |
Revision of a currently approved collection | 2022-05-18 | |
|
Approved without change |
Extension without change of a currently approved collection | 2021-09-07 | |
|
Approved with change |
Reinstatement with change of a previously approved collection | 2018-01-25 | |
|
Approved without change |
Reinstatement with change of a previously approved collection | 2013-09-30 | |
|
Approved with change |
Revision of a currently approved collection | 2009-09-10 | |
|
Approved without change |
Extension without change of a currently approved collection | 2006-05-05 | |
|
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2006-01-20 | |
|
Approved without change |
New collection (Request for a new OMB Control Number) | 2005-11-10 |
Collection of Drug Event Data from Contracted Part D Providers For Payments
Federal Enterprise Architecture: Health - Health Care Services